{"text_format":"2","workbook":"xls","n_sheets":1,"sheets":["report2"],"not_rendered":{"charts":0,"images":0,"macros":0,"external_links":1,"defined_names":1,"comments":0,"pivot_tables":0},"unopened":[],"bounds":{"document_bytes":16777216,"sheet_cells":100000,"run_cost":"one","rows_first":2000,"rows_last":500,"rows_between":2000,"halvings":0,"cell_chars":16384,"cell_head_chars":4096},"cells_cut":0,"cells_raw":0,"read":"whole","date_system":"1900","formulas":"cached_only"}

{"sheet":"report2","index":0,"n_rows":18,"n_cols":5,"rows_kept":18,"cut":false,"hidden":false,"merged":[[0,2,0,3],[0,4,0,5],[1,2,1,3],[1,4,1,5],[2,2,2,3],[2,4,2,5],[3,2,3,3],[4,2,4,3],[5,2,5,3],[6,2,6,3],[7,2,7,3],[10,2,10,3],[11,2,11,3],[15,2,15,3]],"flags":["formulas_cached_only"]}
[null,"1.","Record Nr.",null,"UNINA9910464794803321"]
[null,null,"Autore",null,"Pradelli Lorenzo"]
[null,null,"Titolo",null,"Pharmacoeconomics : principles and practice / / Lorenzo Pradelli, Albert Wertheimer"]
[null,null,"Pubbl/distr/stampa",null,"Torino, Italy : , : SEEd, , 2012"]
[null,null,"ISBN",null,"88-97419-38-0"]
[null,null,"Edizione",null,"[First edition.]"]
[null,null,"Descrizione fisica",null,"1 online resource (125 p.)"]
[null,null,"Soggetti",null,"Drugs - Cost effectiveness"]
[{"$nulls":4},"Pharmacy - Economic aspects"]
[{"$nulls":4},"Electronic books."]
[null,null,"Lingua di pubblicazione",null,"Inglese"]
[null,null,"Formato",null,"Materiale a stampa"]
[null,null,null,"Livello bibliografico","Monografia"]
[null,null,null,"Note generali","Description based upon print version of record."]
[null,null,null,"Nota di bibliografia","Includes bibliographical references."]
[null,null,"Nota di contenuto",null,"\"\"Title Page\"\"; \"\"Colophon \"\"; \"\"Table of Contents\"\"; \"\"Preface\"\"; \"\"Introduction\"\"; \"\"Health Care Dilemma\"\"; \"\"Opportunity Cost\"\"; \"\"Efficiency and Equity\"\"; \"\"Pharmacoeconomics\"\"; \"\"Sensitivity Analysis\"\"; \"\"Summary\"\"; \"\"Further Readings\"\"; \"\"1 Definitions and Basic Concepts\"\"; \"\"1.1 Definitions\"\"; \"\"1.2 Costs\"\"; \"\"1.3 Consequences\"\"; \"\"1.4 Perspectives\"\"; \"\"1.5 Time Horizon\"\"; \"\"2 Pharmacoeconomic Evaluations\"\"; \"\"2.1 Introduction\"\"; \"\"2.2 Cost Analysis\"\"; \"\"2.3 Cost-outcomes Analysis\"\"; \"\"2.4 Utility\"\"; \"\"2.5 Psychometrics\"\"; \"\"3 Modeling Frameworks\"\"; \"\"3.1 Steps in Decision Analysis\"\""]
[{"$nulls":4},"\"\"3.2 Influence Diagrams\"\"\"\"3.3 Markov Models\"\"; \"\"3.4 Discrete-event Simulation\"\"; \"\"3.5 Agent-based Models\"\"; \"\"4 Budget Impact Analysis\"\"; \"\"4.1 Introduction\"\"; \"\"4.2 Example: Budget Impact Analysis of Clinical Guidelines in COPD Patients\"\"; \"\"5 Patient Reported Outcomes\"\"; \"\"5.1 Introduction\"\"; \"\"5.2 From Biological Measures to Patient Reported Outcome\"\"; \"\"5.3 Quality of Life, Health Related Quality of Life, and Patient Reported Outcomes\"\"; \"\"5.4 PRO Dimensions\"\"; \"\"5.5 Every Patient has Individual Health Perceptions\"\"; \"\"5.6 Applications of PRO Instruments\"\""]
[{"$nulls":4},"\"\"5.7 Identifying an Appropriate Instrument for Measuring PRO\"\"\"\"5.8 PRO Instruments\"\"; \"\"5.9 When are the Results of PROs Relevant?\"\"; \"\"5.10 Summary and Conclusion\"\"; \"\"6 Data Sources and Accounting for Uncertainty\"\"; \"\"6.1 Data Sources\"\"; \"\"6.2 Statistical Analysis\"\"; \"\"6.3 Accounting for Uncertainty\"\"; \"\"6.4 Pharmacoeconomic Studies\"\"; \"\"6.5 Conclusions: Evaluating Pharmacoeconomic Studies\"\"; \"\"References\"\"; \"\"Glossary\"\"; \"\"Authors\"\""]